LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
35.28
+1.02 (2.98%)
Jul 11, 2025, 11:56 AM - Market open
LENZ Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
993.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 15.00M | - | - |
| Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionLENZ News
- 4 days ago - LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada - GlobeNewsWire
- 9 days ago - LENZ Therapeutics: Presbyopia Eyedrops Look Promising - Seeking Alpha
- 6 weeks ago - LENZ Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - LENZ Therapeutics, Inc. (LENZ) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia - GlobeNewsWire
- 2 months ago - LENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 2 months ago - LENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care Conference - GlobeNewsWire
- 2 months ago - LENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025 - GlobeNewsWire